Fonar Corp (FONR)
15.24
-0.47
(-2.99%)
USD |
NASDAQ |
May 17, 16:00
15.42
+0.18
(+1.18%)
After-Hours: 20:00
Fonar Cash from Financing (Quarterly): -1.761M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.761M |
| December 31, 2023 | -2.406M |
| September 30, 2023 | -2.126M |
| June 30, 2023 | -1.980M |
| March 31, 2023 | -1.948M |
| December 31, 2022 | -1.883M |
| September 30, 2022 | -1.761M |
| June 30, 2022 | -1.706M |
| March 31, 2022 | -1.44M |
| December 31, 2021 | -1.627M |
| September 30, 2021 | -1.087M |
| June 30, 2021 | -1.650M |
| March 31, 2021 | -1.418M |
| December 31, 2020 | -2.156M |
| September 30, 2020 | -1.386M |
| June 30, 2020 | 0.2732M |
| March 31, 2020 | -1.419M |
| December 31, 2019 | -1.996M |
| September 30, 2019 | -1.763M |
| June 30, 2019 | -1.792M |
| March 31, 2019 | -1.124M |
| December 31, 2018 | -1.958M |
| September 30, 2018 | -1.747M |
| June 30, 2018 | -1.642M |
| March 31, 2018 | -1.745M |
| Date | Value |
|---|---|
| December 31, 2017 | -1.067M |
| September 30, 2017 | -1.846M |
| June 30, 2017 | -2.567M |
| March 31, 2017 | -2.42M |
| December 31, 2016 | -2.644M |
| September 30, 2016 | -3.246M |
| June 30, 2016 | -6.486M |
| March 31, 2016 | -2.047M |
| December 31, 2015 | -2.08M |
| September 30, 2015 | -1.876M |
| June 30, 2015 | -3.068M |
| March 31, 2015 | -6.368M |
| December 31, 2014 | -1.959M |
| September 30, 2014 | -2.11M |
| June 30, 2014 | -3.364M |
| March 31, 2014 | -2.233M |
| December 31, 2013 | -2.615M |
| September 30, 2013 | -2.263M |
| June 30, 2013 | 17.86M |
| March 31, 2013 | 12.73M |
| December 31, 2012 | -0.486M |
| September 30, 2012 | -0.513M |
| June 30, 2012 | -1.504M |
| March 31, 2012 | -0.733M |
| December 31, 2011 | -0.556M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.406M
Minimum
Dec 2023
0.2732M
Maximum
Jun 2020
-1.652M
Average
-1.761M
Median
Sep 2022
Cash from Financing (Quarterly) Benchmarks
| XWELL Inc | 0.00 |
| ProPhase Labs Inc | 2.271M |
| Applied DNA Sciences Inc | 3.015M |
| Veracyte Inc | -0.864M |
| OncoCyte Corp | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 2.807M |
| Cash from Investing (Quarterly) | -0.289M |
| Free Cash Flow | 12.72M |
| Free Cash Flow Per Share (Quarterly) | 0.4054 |
| Free Cash Flow to Equity (Quarterly) | 2.631M |
| Free Cash Flow to Firm (Quarterly) | 2.625M |
| Free Cash Flow Yield | 12.65% |